Novel plasma biomarkers improve discrimination of metabolic health independent of weight.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
07 12 2020
Historique:
received: 15 04 2020
accepted: 18 11 2020
entrez: 8 12 2020
pubmed: 9 12 2020
medline: 18 5 2021
Statut: epublish

Résumé

We sought to determine if novel plasma biomarkers improve traditionally defined metabolic health (MH) in predicting risk of cardiovascular disease (CVD) events irrespective of weight. Poor MH was defined in CATHGEN biorepository participants (n > 9300), a follow-up cohort (> 5600 days) comprising participants undergoing evaluation for possible ischemic heart disease. Lipoprotein subparticles, lipoprotein-insulin resistance (LP-IR), and GlycA were measured using NMR spectroscopy (n = 8385), while acylcarnitines and amino acids were measured using flow-injection, tandem mass spectrometry (n = 3592). Multivariable Cox proportional hazards models determined association of poor MH and plasma biomarkers with time-to-all-cause mortality or incident myocardial infarction. Low-density lipoprotein particle size and high-density lipoprotein, small and medium particle size (HMSP), GlycA, LP-IR, short-chain dicarboxylacylcarnitines (SCDA), and branched-chain amino acid plasma biomarkers were independently associated with CVD events after adjustment for traditionally defined MH in the overall cohort (p = 3.3 × 10

Identifiants

pubmed: 33288813
doi: 10.1038/s41598-020-78478-w
pii: 10.1038/s41598-020-78478-w
pmc: PMC7721699
doi:

Substances chimiques

Biomarkers 0
Lipoproteins 0
Lipoproteins, HDL 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

21365

Subventions

Organisme : NIH HHS
ID : R01-HL127009
Pays : United States
Organisme : American Heart Association-American Stroke Association
ID : 17SFRN33670990
Pays : United States
Organisme : NHLBI NIH HHS
ID : 5P01-HL036587
Pays : United States

Références

Metab Syndr Relat Disord. 2014 Oct;12(8):422-9
pubmed: 24959989
Am Heart J. 2010 Sep;160(3):371-379.e2
pubmed: 20826242
Circulation. 2004 Sep 7;110(10):1245-50
pubmed: 15326067
Endocr Rev. 2008 Dec;29(7):777-822
pubmed: 18971485
Arch Intern Med. 2008 Aug 11;168(15):1617-24
pubmed: 18695075
Clin Chem. 2017 Jan;63(1):288-296
pubmed: 27811210
Circ Res. 2018 Apr 27;122(9):1238-1258
pubmed: 29700070
Clin Chem. 2016 Jul;62(7):1020-31
pubmed: 27173011
Clin Lab. 2002;48(3-4):171-80
pubmed: 11934219
JAMA. 2001 May 16;285(19):2486-97
pubmed: 11368702
PLoS One. 2015 Mar 03;10(3):e0118998
pubmed: 25734639
Circulation. 2004 Feb 17;109(6):706-13
pubmed: 14970104
Atherosclerosis. 2016 Mar;246:229-35
pubmed: 26803432
J Card Fail. 2002 Aug;8(4):216-24
pubmed: 12397569
Eur J Prev Cardiol. 2018 May;25(8):830-838
pubmed: 29537291
Am Heart J. 2012 May;163(5):844-850.e1
pubmed: 22607863
BMC Public Health. 2009 Mar 25;9:88
pubmed: 19320986
Circ Cardiovasc Genet. 2010 Apr;3(2):207-14
pubmed: 20173117
Metabolism. 2013 Jul;62(7):961-9
pubmed: 23375209
Am J Cardiol. 2015 Mar 1;115(5):557-62
pubmed: 25727079
Lancet. 2014 Aug 16;384(9943):618-625
pubmed: 25131981
Curr Opin Clin Nutr Metab Care. 2016 Nov;19(6):408-417
pubmed: 27552473
Clin Nutr. 2019 Oct;38(5):2311-2318
pubmed: 30482563
J Am Coll Cardiol. 2003 Dec 3;42(11):1933-40
pubmed: 14662255
PLoS Genet. 2015 Nov 05;11(11):e1005553
pubmed: 26540294
Circulation. 2006 Mar 28;113(12):1556-63
pubmed: 16534013
Circulation. 2018 Mar 20;137(12):e67-e492
pubmed: 29386200
Atherosclerosis. 2014 Jan;232(1):191-6
pubmed: 24401236
JAMA Cardiol. 2017 Aug 1;2(8):896-901
pubmed: 28492915
Circ Res. 2016 Apr 1;118(7):1106-15
pubmed: 26951635
Ann Epidemiol. 2012 May;22(5):349-53
pubmed: 22305325
Diabetologia. 1985 Jul;28(7):412-9
pubmed: 3899825
J Cardiovasc Pharmacol Ther. 2017 Jul;22(4):365-367
pubmed: 28587579
J Thorac Cardiovasc Surg. 2012 Apr;143(4):873-8
pubmed: 22306227

Auteurs

Stephen Ellison (S)

Department of Anesthesiology, Duke University Medical Center, Durham, NC, USA.

Jawan W Abdulrahim (JW)

Duke Molecular Physiology Institute, Duke University School of Medicine, 300 North Duke St, Durham, NC, 27701, USA.

Lydia Coulter Kwee (LC)

Duke Molecular Physiology Institute, Duke University School of Medicine, 300 North Duke St, Durham, NC, 27701, USA.

Nathan A Bihlmeyer (NA)

Duke Molecular Physiology Institute, Duke University School of Medicine, 300 North Duke St, Durham, NC, 27701, USA.

Neha Pagidipati (N)

Division of Cardiology, Department of Medicine, Duke University School of Medicine, Durham, NC, USA.

Robert McGarrah (R)

Duke Molecular Physiology Institute, Duke University School of Medicine, 300 North Duke St, Durham, NC, 27701, USA.
Division of Cardiology, Department of Medicine, Duke University School of Medicine, Durham, NC, USA.

James R Bain (JR)

Duke Molecular Physiology Institute, Duke University School of Medicine, 300 North Duke St, Durham, NC, 27701, USA.

William E Kraus (WE)

Duke Molecular Physiology Institute, Duke University School of Medicine, 300 North Duke St, Durham, NC, 27701, USA.
Division of Cardiology, Department of Medicine, Duke University School of Medicine, Durham, NC, USA.

Svati H Shah (SH)

Duke Molecular Physiology Institute, Duke University School of Medicine, 300 North Duke St, Durham, NC, 27701, USA. svati.shah@duke.edu.
Division of Cardiology, Department of Medicine, Duke University School of Medicine, Durham, NC, USA. svati.shah@duke.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH